Subtypes of neuronal nicotinic acetylcholine receptors (nAChR) are differentially sensitive to upregulation by chronic nicotine in vitro. To determine whether this occurs in animals, rats were implanted with minipumps containing saline +/-nicotine (6.0 mg/kg/rat/day) for 14 days.
with the rat brain atlas of Paxinos and Watson (1998) . Under these conditions, nonspecific binding in adjacent sections was not distinguishable from film background and therefore total binding was identical to specific binding. Because the working exposure range of the autoradiographic film is smaller than the range of binding densities of high affinity neuronal nicotinic receptors, regions with exceptionally high receptor densities can easily be "overexposed." Therefore, quantitation for several such regions (including medial habenula, fasciculus retroflexus, interpeduncular nucleus and superior colliculus) was done using the 6 hr exposure; all others were determined from the 4 day exposure. Note that while a large number (33) of regions were assessed, this was not an exhaustive survey of binding in all brain regions.
Determination of subtype-selective binding was done according to a previously published method (Perry et al., 2002) . Briefly, this method assumes that total [ 125 JPET #56408 9 different combinations of subunits expressed in vitro (Perry et al., 2002) , it is possible to divide [ 125 I]epibatidine binding into "4$2-like, "3/"6$2-like and "3$4-like binding using the differential affinities of the three ligands to receptors in heterologous expression systems. While [ 125 I]epibatidine binds with high affinity to all three subtypes (K d s, nM: "4$2, 0.17; "3$2, 0.10; "3$4, 1.1), A-85380 has high affinity for only the α4β2 and "3/"6$2 subtypes (K i s, nM:
"4$2, 0.11; "3$2, 0.16; "3$4, 59) and cytisine is relatively selective for the α4β2 subtype (K i s, nM: "4$2, 1.7; "3$2; 47; "3$4, 240). "2 nAChR were not considered in this analysis due to the very limited expression of this subunit (Wada et al., 1989) .
For every region, we made three separate measurements of [ chosen to yield a partial, but not complete, blockade of "4$2 and "3/"6$2 receptors (by A-85380) and "3$2 and "3/"6$2 receptors (by cytisine). Our previous publication describing this method (Perry et al., 2002) As discussed above, each of these "subtypes" may include multiple subunit combinations.
Therefore we use the terminology ""4$2-like binding" to acknowledge this heterogeneity. Also, the method is based on the assumption that all [ 125 I]epibatidine binding can be accounted for by these three subtypes. Although this is a reasonable assumption for most regions, it may not hold for every area: for example, while "2 subunits are not commonly found in mammalian CNS, they are expressed in the interpeduncular nucleus (Wada et al., 1989) . Cell binding data for the "6$2 subtype is not available, so identification of this subclass is based on similarities to the "3$2 subtype. The calculations depend on data obtained using rat subunits expressed in HEK-expression, or low expression of a subtype, are likely to be less reliable; we have restricted our analysis of subtypes to regions in which that subtype comprised $10% of the total binding.
Means for total binding and for binding to the three subtype classes were determined for saline and nicotine treated animals (nine animals per group) and compared by t-test without correction for multiple comparisons. Statistical significance is expressed as *p<0.05; **p<0.01; ***p<0.001.
This article has not been copyedited and formatted. The final version may differ from this version. interpeduncular nucleus, fasciculus retroflexus) was done using separate films exposed for shorter times, to rule out film saturation artifacts. Results in Table 1 show a 73-fold range in binding densities among the regions assessed. In the great majority of these regions (23 of 33), chronic exposure to nicotine significantly increased binding, in some cases to levels almost three times those seen in saline-treated animals. The greatest increases in total binding were detected in forebrain regions, including cerebral cortex, amygdala, dentate gyrus, and nucleus accumbens. Increased total [ 125 I]epibatidine binding was not seen in the habenulo-peduncular regions, subiculum, posterior thalamic nuclear group, dorsal lateral geniculate nuclei, subiculum, nucleus of the solitary tract, area postrema or pineal gland.
To determine subtype-selective binding, adjacent sections were exposed to [ 125 I]epibatidine either alone or in the presence of the unlabeled competitors A-85380 (1 nM, which competes against $2-containing receptors) or cytisine (50 nM, which competes against "4$2, and to a lesser extent "3/"6$2, receptors). An example of this competition is shown in Nicotine is a full agonist at "4$2 receptors but only a partial agonist at "3$2 receptors (Olale et , 1997; Chavez-Noriega et al., 2000) , which could contribute to a differential response between these two subtypes. However, nicotine is a full agonist at "3$4 receptors, the most resistant subtype to upregulation.
Upregulation of nAChR is not thought to be caused by increased mRNA expression.
Possible mechanisms include a decreased rate of subunit degradation (Marks et al., 1992; Peng et al., 1994; Ke et al., 1998) , alone or in concert with other mechanisms, including posttranslational modification such as phosphorylation, enhanced subunit assembly, and altered subcellular distribution (Wang et al., 1998; Ke et al., 1998) . Under normal circumstances, most subunit proteins existed in an unassembled form within the ER: chronic nicotine enhances both assembly of subunits, and insertion into the plasma membrane (Harkness and Millar, 2002).
Differences in subtype susceptibility to these various mechanisms may contribute to differences in subtype sensitivity to upregulation. In a possibly related finding, chronic nicotine has been shown to alter stoichiometry within a subtype, causing an apparent shift from ("4) 3 ($2) 2 to ("4) 2 ($2) 3 in HEK cells (Nelson et al., 2003) .
Besides differences in sensitivity of nAChR subtypes to upregulation, this study highlights an interesting regional variability in upregulation within a subtype. For instance, "3/"6$2 binding was unaffected in most regions, but showed significant upregulation in two regions. The increase of 46% in the superior colliculus, a structure innervated by the optic tract, The precise subunit identity of "3/"6$2-like binding is uncertain. Initial studies identified this class as "3$2, based on inhibition by "-conotoxin MII (Cartier et al., 1996; Whiteaker et al., 2000) . Evidence now indicates that in most brain regions, the nAChR identified by this toxin contain "6, perhaps along with "3 subunits in some regions (Quik et al., 2001; Champtiaux et al., 2002; Marubio et al., 2003) . Most are likely to be paired with $2 subunits, and in some cases also $3 or "4 subunits (Lena et al., 1999; Klink et al., 2001; Champtiaux et al., 2002; Whiteaker et al., 2002; Marubio et al., 2003) . In analogy to mouse nAChRs, a likely pattern is that rat "6-containing receptors are found in catecholaminergic regions (i.e. caudate putamen, nucleus accumbens), and probably also in visual structures (optic tract and nuclei and superior colliculus) (Le Novere et al., 1996; Lena et al., 1999; Klink et al., 2001; Whiteaker et al., 2002) , whereas the labeling in habenulo-peduncular structures may be due at least in part to "3$2 receptors (Whiteaker et al., 2002) . Thus one possible explanation for the regional differences in sensitivity to upregulation is "6 vs. "3 heterogeneity. No increases of "3/"6$2 binding were detected in the habenulo-peduncular structures, suggesting that the "3$2 subtype in brain may not be upregulated. Not all of the differences in sensitivity can be explained by this, because in several other regions also presumed to contain "6 receptors (i.e. caudate putamen, geniculate nuclei), no evidence for upregulation was seen. These differences could also be caused by further subunit differences, such as additional subunit heterogeneity. We are not aware of previous reports for regulation of "6* receptors by chronic Acb, nucleus accumbens; CPu, caudate putamen; DG, granule layer, dentate gyrus;
MHb, medial habenula; opt, optic tract; RSG, retrosplenial granular cortex; SNC, substantia nigra pars compacta. 
